UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in HRMY — Harmony Biosciences Holdings, Inc.
CIK 861177
NEW YORK, NY
Position in HRMY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$3,063,171
-$901,362 QoQ
Shares Held
84,130
-40.6% QoQ
Ownership
0.144%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#85
of 328 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 47%
Shared 0%
None 53%
Common Shares in HRMY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,385,897,555 across 206 Biotechnology names. HRMY ranks #86 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,086,683 | $1,533,248,041 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
716,560 | $446,803,817 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
727,848 | $219,104,078 | |
| 4 | INCY |
Incyte Corp
|
1,508,720 | $171,028,494 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
912,335 | $170,862,094 | |
| 6 | INSM |
INSMED Inc
|
1,335,071 | $142,345,265 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
1,454,672 | $115,340,938 | |
| 8 | MRNA |
Moderna, Inc.
|
1,521,849 | $106,575,080 |
All Filings in HRMY
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,063,171 | 84,130 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $3,964,533 | 141,540 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $5,236,515 | 139,939 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $1,925,614 | 69,870 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $4,143,516 | 131,124 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $3,165,959 | 95,389 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $2,144,808 | 62,331 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $2,466,120 | 61,653 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $2,062,780 | 68,372 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,235,037 | 36,779 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,187,959 | 36,779 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,261,381 | 38,492 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $444,061 | 12,619 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $412,009 | 12,619 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,713,607 | 31,100 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,098,036 | 24,792 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $857,521 | 17,583 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $855,411 | 17,583 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $512,701 | 12,024 | Shares | Defined | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||